Post-earnings recap
Reported
Thu, Apr 30, 2026
EPS actual
$1.60
EPS est.
$1.51
EPS surprise
+6.17%
1-day move
-2.54%
Encompass Health Corporation reported better-than-expected earnings per share, which indicates strong performance relative to analyst expectations. However, the stock fell by 2.54% in reaction, suggesting that investors may have been disappointed by the lack of revenue information or future guidance. The absence of management commentary could also contribute to uncertainty among investors.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $1.60 | $1.49 | +6.17% |
| Revenue | N/A | $1.6B | N/A |
No transcript is on record, and the analysis is based on numerical results only.
Encompass Health Corporation is a healthcare company that specializes in providing rehabilitation services. With a market cap of $10 billion, it plays a significant role in the health care facilities sector, which is increasingly focused on improving patient outcomes and efficiency in care delivery.
Last quarter
In Q4 2025, Encompass Health reported an EPS of $1.46, exceeding estimates by 12.92%. The stock reacted positively, increasing by 4.08% the following day.
Management promises and guidance
EPS beat streak
8Q
EPS beat rate
100%
Avg EPS surprise
+10.42%
Avg 1-day reaction
-0.12%
Analysts expect Encompass Health to report strong earnings this quarter, with a consensus EPS of $1.49 and revenue of $1.6 billion.
Bull case
If the company beats EPS estimates, it could signal strong operational performance and growth, potentially leading to a stock price increase.
Bear case
If the company falls short of expectations, it may raise concerns about its ability to sustain growth in a competitive healthcare market.
Key metrics to watch
Earnings Per Share (EPS)
$1.49EPS is a key indicator of the company's profitability and is closely watched by investors.
Revenue
$1.6BRevenue figures provide insight into the company's overall sales performance and growth potential.
The print will turn on these.
Q1
Will Encompass Health achieve an EPS of $1.49 or higher?
This number is crucial as it will indicate the company's profitability and operational efficiency, which are key to investor confidence.
Q2
How will revenue growth compare to the $1.6 billion consensus?
Revenue performance will provide insight into the company's market position and ability to grow in a competitive environment.
—
Est. EPS
$2.79
Est. Rev
$8.9B
Impl. Move
±2.9%
Why consensus could be wrong
The consensus may underestimate the potential for Encompass Health to exceed EPS expectations due to its strong operational improvements and demand for rehabilitation services.
Supporting evidence
The company has consistently beaten EPS estimates in recent quarters, indicating strong performance.
Options pricing suggests a higher volatility expectation, which may reflect investor confidence in a positive surprise.
Key risk
If EPS comes in below $1.38, it could challenge the current bullish sentiment.
Pre-commit to what would confirm each case.
This quarter's performance will be closely scrutinized as it reflects the company's ability to navigate a challenging healthcare landscape.
Bull confirmed if
An EPS of $1.53 or higher would confirm strong operational performance.
Bear confirmed if
An EPS below $1.38 would raise concerns about profitability.
What the market is pricing for the move.
Implied Move
±6.35%
Historical Avg
±1.6%
The options market is pricing in a significant move, suggesting that investors anticipate volatility around the earnings announcement.
Options are pricing ±6.4% while EHC has averaged ±1.6% over the last 8 prints — setup is pricing rich.
ATM IV
0.5%
30d HV
26.2%
Cross-company pattern from 30 similar setups.
Prior-quarter beat + options rich in Health Care
Fade rate: 7 of 23 (30%)
This setup has occurred 30 times across Health Care in the last 2 years. 16 of 23 (70%) held or extended their move within 5 days — this setup typically holds direction. The average absolute 1-day move is 4.2%, with a raw directional average of +0.6% (modestly positive historical bias).
Smart-money positioning from the most recent 13F filings.
Institutional
100.90%
of float
Insider
0.87%
of float
Holders
808
institutions
Top Holders· as of Jun 2026
Blackrock Inc.
10,484,385 sh · $1.3B
10.63%
-2.6%
Likely market behavior by outcome. Not investment advice.
Beat & raise
If Encompass Health beats expectations, history suggests a potential average one-day move of +1.72%, confirming strong operational momentum.
In line / cautious
If results are in line with expectations, the stock may see muted movement as investors await further guidance.
Miss
A miss could lead to a decline, with historical patterns suggesting an average one-day move of -0.21% when expectations are not met.
The lines on the call that would change the story.
Price (T.Rowe) Associates Inc
5,055,801 sh · $619.2M
5.12%
9.9%
Vanguard Portfolio Management LLC
4,924,664 sh · $603.2M
4.99%
-0.7%
Vanguard Capital Management LLC
4,475,896 sh · $548.2M
4.54%
0.2%
Wellington Management Group, LLP
3,278,739 sh · $401.6M
3.32%
-14.8%
13F filings updated quarterly. Position deltas show change in shares vs. the prior quarter.